Evolus Expands Aesthetic Portfolio with Exclusive U.S. Licensing Agreement for Profhilo®, Europe’s Leading Injectable Skin Quality Treatment Evolus, Inc., a global performance beauty company focused on developing innovative consumer aesthetic brands, has announced an exclusive licensing and distribution agreement with…
U of T, McMaster and Genesys Capital Launch Early-Stage Life Sciences Fund A major new venture capital initiative is set to strengthen Ontario’s life sciences ecosystem by providing early-stage funding to promising health technology startups emerging from academic research. The…
Turn Therapeutics Finalizes Phase 2 Study Design for GX-03 Following Positive Interim Analysis in Atopic Dermatitis Turn Therapeutics, Inc., a clinical-stage biotechnology company focused on developing targeted, non-systemic therapies for inflammatory skin disorders, has announced the completion of a comprehensive…
Agenus Reports Landmark Three-Year Phase 1b Data Showing Durable Survival with Botensilimab Plus Balstilimab in Refractory MSS Metastatic Colorectal Cancer Agenus Inc., a biotechnology company focused on advancing next-generation immuno-oncology therapies, has announced encouraging three-year follow-up data from its fully…
Alzheon to Present Nine Scientific Posters at AAIC 2026 Highlighting New Clinical, Imaging, Biomarker, and Long-Term Data for Investigational Alzheimer’s Therapy Valiltramiprosate Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing therapies and diagnostic technologies for Alzheimer’s disease (AD) and…
VIVAZEN Welcomes DEA Scheduling of Synthetic 7-Hydroxymitragynine, Reinforces Commitment to Safe Botanical Wellness and Consumer Transparency VIVAZEN®, a leading botanical wellness company in the United States, has welcomed the recent decision by the U.S. Drug Enforcement Administration (DEA) to classify…
HeartBeam Completes Patient Enrollment Ahead of Schedule in ALIGN-ACS Pilot Study for Heart Attack Detection HeartBeam, Inc., a medical technology company focused on advancing cardiovascular diagnostics through innovative electrocardiogram (ECG) technology, has announced the successful completion of patient enrollment in…
Tenpoint Therapeutics Launches National ‘Friends of the Presbyopians’ Campaign to Raise Awareness of YUVEZZI for Age-Related Near Vision Loss Tenpoint Therapeutics, Ltd., a global commercial ophthalmic pharmaceutical company dedicated to developing innovative therapies that improve vision in the aging eye,…
Novo Nordisk to Showcase New Haemophilia Research and Investigational Denecimig Data at ISTH 2026 Congress Novo Nordisk has announced that it will present an extensive portfolio of new scientific data at the 34th International Society on Thrombosis and Haemostasis (ISTH)…
Stallergenes Greer Earns 2026 Switzerland’s Best Managed Companies Award for Excellence in Leadership, Innovation, and Sustainable Growth Stallergenes Greer, a global leader in allergy immunotherapy and allergy care, has been honored with the prestigious 2026 Switzerland’s Best Managed Companies Award,…
FIRST Survey Highlights the Emotional, Social, and Daily Challenges Faced by People Living with Ichthyosis, Reinforcing the Need for Better Treatments and Support The Foundation for Ichthyosis & Related Skin Types (FIRST) has released the findings of its comprehensive Patient…
CEL-SCI and Saudi Amarox Formalize Partnership at BIO 2026 to Advance Oncology Innovation in Saudi Arabia CEL-SCI Corporation announced that it has officially completed a formal signing ceremony with Saudi Amarox during the BIO International Convention 2026 in San Diego,…